Sunday Surprises


UIC John Marshall Law School Center for Intellectual Property, Information & Privacy Law
Music Copyright Infringement: Global Perspective” (18 March 2022 | online)

On March 18, 2022, UIC LAW's Center for Intellectual Property & Privacy Law will host a conference on how courts in Asia, Europe, and North America adjudicate music copyright infringement disputes. Topics will include access and substantial similarity, fair use, performers' rights, moral rights, expert testimony, the role of lay listeners, sound sampling as it appears in court and out-of-court litigation. For more information and to register, click here.

EPIP | Innovation and IP Management (IIPM) Laboratory and the Centre for IP and Information Law (CIPIL)
Opening IP for a better world?” (14-16 September 2022 | IIPM/CIPIL)

EPIP, the Association for European Intellectual Property Policy, has issued a call for papers, soliciting submissions for its 17th annual conference, "Opening IP for a better world?" The conference will be held September 14-16, 2022, in Cambridge, United Kingdom, and will be hosted by the Innovation and IP Management (IIPM) Laboratory and the Centre for IP and Information Law (CIPIL). More information and submission guidelines can be found here.


European Commission
News | Trade barriers: Case on measures affecting trade of “Tequila” resolved

On February 3, 2022, the European Commission formally closed its investigation under the EU Trade Barriers Regulation (TBR) into Mexican measures against the export of "Tequila" after successfully resolving the matter. The complaint had been filed by Brewers of Europe, which argued that Mexico's refusal to issue export certificates for "Tequila" was incompatible with WTO rules and caused significant economic harm to an EU company that relies on "Tequila" as an input. In the course of its investigation, the Commission expressed concerns to the Mexican authorities about the WTO compatibility of the measure. The measure was also challenged by the exporter concerned in domestic courts in Mexico. In October 2021, the complainant informed the Commission that the EU company concerned had reached a solution with the Mexican authorities that would allow the removal of the alleged trade barrier. As a result of this development, Brewers of Europe has withdrawn its TBR complaint. Read more about the background and the TBR complaint by the TechieKat here.


BIICL course
"Pharmaceuticals and Intellectual Property" (from 4 March to 13 May 2022)

The British Institute of International and Comparative Law (BIICL) will hold the online course Pharmaceuticals and Intellectual Property from 4 March to 13 May 2022. The course consists of 10 sessions via Zoom. It is addressed to legal practitioners, students, and law academics interested in the link between public health and intellectual property. The topics include inter alia pharmaceutical industry and national systems of innovation; intellectual property and product regulation; international intellectual property and trade law; access to medicines: from HIV/AIDS to COVID-19; and alternative pharmaceutical innovation models. The trainers are Professors Graham Dutfield (University of Leeds) and Uma Suthersanen (Queen Mary University of London). The course cost is £700. Discounts and scholarships are available. Applications for scholarships must be submitted before 11 February 2022. More information here.

Sunday Surprises Sunday Surprises Reviewed by Giorgio Luceri on Sunday, February 06, 2022 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here:

Powered by Blogger.